SERB's Financial Acquisition

SERB raised a round of funding on June 09, 2017. Investors include Charterhouse Capital Partners.

SERB is a European specialty pharmaceutical group that focuses on niche branded prescription drugs for use in areas of medicine including critical and emergency care, neurology, diagnostics, and endoc…

Articles about SERB's Financial Acquisition: